Ron Gutman, inventor, serial healthcare and technology entrepreneur, and Stanford University adjunct professor, discusses the emergence of genomic sequencing as a vital tool in mitigating global public health threats.
Sabine Mai and Aline Rangel-Pozzo from CancerCare Manitoba Research Institute, The University of Manitoba, explore how 3D imaging and quantitative analysis provide key insights into genomic instability.
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explains how glycoscience offers opportunities galore in healthcare.
The study, published in The Lancet Digital Health, found that deep learning tech had an average accuracy of 88% when it came to diagnosing genetic syndromes.
A new study confirms that antimicrobial resistance increases as people travel internationally, with one scientist commenting that the world faces "a worrisome problem on the horizon".
A team at Newcastle University have identified a gene, HLA-DRB1*04:01, which could be responsible for individuals who are asymptomatic - suggesting that the gene offers some protection against severe COVID.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, provides a portrait of a ground-breaking technology, next-generation sequencing, starting with a brief snapshot.
The NSF’s Division of Integrative Organismal Systems, within the Directorate for Biological Sciences, discusses how their work determining phenotype from genotype is fighting food insecurity.
Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.
Professors Darren Griffin and Mike Bruford (Universities of Kent and Cardiff) discuss what is meant by a “whole genome sequence” and how it is revolutionising conservation efforts.
Dr Craig Titmus, Partner and UK and European Patent Attorney at intellectual property firm, Mathys & Squire, turns the spotlight on genomics and public health from a patent attorney’s perspective.
